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Skeletal muscles are formed in numerous shapes
and sizes, and this diversity impacts function and
disease susceptibility. To understand how muscle
diversity is generated, we performed gene expres-
sion profiling of two muscle subsets from Drosophila
embryos. By comparing the transcriptional profiles
of these subsets, we identified a core group of
founder cell-enriched genes. We screened mutants
for muscle defects and identified functions for
Sin3A and 10 other transcription and chromatin reg-
ulators in the Drosophila embryonic somatic muscu-
lature. Sin3A is required for the morphogenesis of a
muscle subset, and Sin3A mutants display muscle
loss andmisattachment. Additionally, misexpression
of identity gene transcription factors in Sin3A hetero-
zygous embryos leads to direct transformations of
one muscle into another, whereas overexpression
of Sin3A results in the reverse transformation. Our
data implicate Sin3A as a key buffer controlling mus-
cle responsiveness to transcription factors in the for-
mation of muscle identity, thereby generating tissue
diversity.
INTRODUCTION
Skeletal muscles exist in a range of shapes and sizes specific
to their functions. This diversity manifests itself not only in
distinct morphologies but also in differing susceptibilities to dis-
eases like muscular dystrophy (Cardamone et al., 2008). The
Drosophila somatic musculature provides an ideal system to
address the mechanisms underlying muscle diversity. In the
Drosophila embryo, a repeated pattern of 30 distinct muscle
fibers is present in each abdominal hemisegment (Figure 1A).
Despite similarities, such as shared expression of contractile
proteins, each muscle fiber can be distinguished by properties
like its size, shape, orientation, number of nuclei, innervation,
and tendon attachment sites (Baylies et al., 1998). Muscle fibers
arise by the iterative fusion of two types of myoblasts, called
founder cells (FCs) and fusion competent myoblasts (FCMs), to858 Cell Reports 8, 858–870, August 7, 2014 ª2014 The Authorsform a syncytium (Rochlin et al., 2010). In fusion mutants, single
FCs develop and extend processes toward their attachment
sites, indicating that FCs contain the information required to
direct morphogenesis of each specific muscle (Rushton et al.,
1995). This information is encoded by DNA-binding transcription
factors expressed in incompletely overlapping subsets of FCs,
known as the FC identity genes (Beckett and Baylies, 2006; Tix-
ier et al., 2010). Over a dozen identity genes have been identi-
fied, including the zinc-finger transcription factor Kru¨ppel (Kr)
(Ruiz-Go´mez et al., 1997) and the homeodomain proteins slouch
(slou) (Dohrmann et al., 1990), apterous (ap) (Bourgouin et al.,
1992), and araucan/caupolican (ara/caup) (Carrasco-Rando
et al., 2011).
The process by which identity genes determine final muscle
characteristics is not fully understood. The combinatorial code
hypothesis predicts that each FC has a distinct gene expression
profile leading to the adoption of unique muscle characteristics
(Tixier et al., 2010). While previous studies examined the differ-
ences in gene expression between FCs and FCMs, no study
has compared distinct groups of FCs (Artero et al., 2003; Busser
et al., 2012; Estrada et al., 2006). It is therefore unknown how
different each set of FCs is from another set and what genes
contribute to the establishment of muscle diversity.
The chromatin regulator Sin3A is conserved from yeast to
humans, serving as a scaffold protein for the Sin3/histone de-
acetylase (HDAC) complex (Grzenda et al., 2009; Silverstein
and Ekwall, 2005). Though initially characterized as a repressor,
Sin3/HDAC has been implicated in both positive and negative
regulation of transcription via its role in chromatin modification.
Sin3/HDAC has many roles in development, particularly in mus-
cle (Cunliffe, 2008; Sharma et al., 2008; Sheeba et al., 2007; Shi
and Garry, 2012; van Oevelen et al., 2008, 2010). In the chick,
Sin3A has been shown to be important in the development of
rostral presomitic mesoderm and fully formed somites (Sheeba
et al., 2007; Tomancak et al., 2002). Mice with reduced levels
of Sin3A in muscle exhibit disruption of the sarcomere, and
depletion of Sin3A from C2C12myoblast cells results in downre-
gulation of a number of genes important for somitogenesis and
sarcomere formation (van Oevelen et al., 2010). Interestingly,
no prior role has been discovered in these systems for Sin3A in
the formation of specific muscle identities.
An intriguing aspect of muscle development in Drosophila has
been that direct transformations of onemuscle into another have
been very rarely observed, though they might have been ex-
pected when identity genes are misregulated. These observa-
tions have led us to hypothesize that only certain muscles in
the pattern are competent to respond to individual identity
genes. One explanation for the differential competency of
muscles is alteration in chromatin structure, but no chromatin
regulators had been shown to be important for this process in
Drosophila. Here, we use a combination of fluorescence-acti-
vated cell sorting (FACS), microarray, and mutant analysis to
identify 11 genes not previously characterized in Drosophila em-
bryonic muscle development. We report a role for the chromatin
regulator Sin3A in muscle morphogenesis as well as in the adop-
tion of muscle identity. Our work indicates that one important
role for Sin3A is to guarantee that cells are competent to respond
to information from identity genes, thus ensuring muscle identity
and, ultimately, tissue diversity.
RESULTS
FACS Purification and Microarray Analysis of Muscle
Founder Cells
To identify FC-specific genes and other factors contributing to
muscle diversity, we performed microarray analysis on fluores-
cence-activated cell-sorted populations of FCs from dissoci-
ated embryos at late stage 12/early stage 13 (8–10 hr after
egg laying [AEL]). These embryos expressed one of two fluo-
rescent transgenes in a subset of muscle FCs under the control
of an identity gene promoter: apME-GFP (Figure 1A) or slouME-
RFP (Figure 1B) (Richardson et al., 2007; Schnorrer et al.,
2007). twistprom-actin::GFP labels both FCs and FCMs and
was used as a control (Figure 1C) (Richardson et al., 2007).
Sorting of FC subsets has not been done previously. These
cells represented a very small percentage of the overall cells
in the embryo; for apME-GFP, the sorted cells comprised only
0.02% of total dissociated embryonic cells. We, however,
purified sufficient material for sample amplification to be unnec-
essary. RNA from these samples was used for microarray
analysis (see Experimental Procedures). We analyzed these mi-
croarray data, generating lists of genes that are differentially
regulated in FCs (Table S1).
Weusedseveral approaches tovalidateourarraydata.First,we
confirmed thepresenceof expectedmuscle genes, like themeso-
dermal transcription factors twist,DMef2, andpoxmeso, in our list
of upregulated genes (Baylies and Bate, 1996; Duan et al., 2007;
Lilly et al., 1994; Nguyen et al., 1994; Taylor et al., 1995). Our lists
shared a large number of genes with an RNAi screen in fly
adult muscle (Table S2) (Schnorrer et al., 2010). Next, we cross-
referenced over 100 upregulated genes with a mesodermal
whole-genome chromatin immunoprecipitation (ChIP) study and
discovered that 94% of these genes had Twist or DMef2 binding
sites within 30 kb, suggesting somatic mesoderm expression
(Zinzen et al., 2009) (Table 1 and data not shown).
Upon comparison of our lists of upregulated genes, we
observed significant overlap between the two muscle subsets.
This result suggested that a core gene expression profile
defines FCs, with few genes controlling later diversification of
muscle types (Figure 1D). In situ hybridization analysis of over
150 array-identified genes revealed that 80% were expressedwithin the somatic mesoderm (Table S3; Figure S1). A compari-
son of our upregulated lists of genes with ImaGO terms
describing embryonic gene expression revealed an enrichment
for the terms ‘‘muscle cell primordium’’ and ‘‘embryonic and
larval somatic muscle’’ (Table S2) (Tomancak et al., 2002). Using
the Database for Annotation, Visualization and Integrated Dis-
covery (DAVID), we also identified a number of Biological Func-
tion Gene Ontology (GO) categories that were enriched in our
upregulated gene lists (Figure 1E) (Huang et al., 2009a, 2009b).
Significantly enriched GO categories represent many functions
important for myogenesis, including muscle cell differentiation
pattern specification, cell morphogenesis, actin cytoskeleton
regulation, and microtubule-based processes.
Many of the genes common to both FC subsets encode general
regulators of transcription, including TAFs, elongation factors, and
componentsof transcriptional activator and repressor complexes.
Such genes might be expected to be essential for a regulatory
cascade, altering expression of downstream signaling and cell
morphogenesis molecules responsible for differentiating FCs
from FCMs. We focused on transcription factors and chromatin
regulators to identify regulators of muscle morphogenesis.
Identification of Regulators of Drosophila Embryonic
Muscle Morphogenesis
We conducted further analysis on FC-upregulated genes with
confirmed mesodermal expression by in situ hybridization (Fig-
ure S1). We assessed the muscle pattern in available mutants
and identified muscle defects in embryos homozygous for
mutations in 11 genes not previously implicated in somatic
muscle morphogenesis (Figures 2A–2N; Table 1; Figure S2).
These encode the previously uncharacterized zinc-finger pro-
tein CG8145, which we have named Numerous disorderedmus-
cles (Nom); zinc-finger proteins Longitudinals lacking (Lola),
Alhambra (Alh), and Charlatan (Chn); basic-helix-loop-helix
(bHLH) protein Cropped/dAP-4 (Crp); elongation factor and E3
ubiquitin ligase complex member Elongin-B (Elo-B); Mediator
complex member Med13/Skuld/Blind spot (Med13); and chro-
matin modifiers Little imaginal discs (Lid), Lysine-specific deme-
thylase 2 (Kdm2), Grunge/Atrophin (Gug), and Sin3A (Figures
2B–2M) (Aso and Conrad, 1997; Boube et al., 2000; Erkner
et al., 2002; Escudero et al., 2005; Gildea et al., 2000; King-Jones
et al., 1999; Lagarou et al., 2008; Linder et al., 2001; Pennetta
and Pauli, 1998; Seeger et al., 1993). With the exception of
the previously uncharacterized gene nom, all other genes are
conserved in vertebrates (Table 1). Mutants displayed a
range of defects, including muscle loss, missing or incorrect
attachments, shape changes, or extra muscles. Gene specificity
for each mutant allele was confirmed by examining embryos
bearing the mutant allele in trans to a deficiency (Figure 2),
and, when available, multiple mutant alleles for each gene
were screened (data not shown). Homozygous mutants were
also found to have muscle defects (Figure S2). No two genes
displayed the same pattern of embryonic muscle defects, sug-
gesting at least some independent functions for each factor.
To show that the observed muscle defects in these mutants
were the result of loss of gene function in the mesoderm, we
examined the cuticle of mutant embryos to determine whether
overall embryonic patterning was disrupted; we did not detectCell Reports 8, 858–870, August 7, 2014 ª2014 The Authors 859
(legend on next page)
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Table 1. Genes that Were Identified as Upregulated in the Somatic Mesoderm by Microarray Analysis
Gene FlyBase Gene ID Mammalian Homolog Protein Type
Mesodermal-Specific Transcription
Factor Binding Sites
chn FBgn0015371 — zinc-finger containing Twi and DMef2
50 and intron
Lid FBgn0031759 Kdm5 histone demethylase Twi and DMef2
30
Med13 FBgn0003415 Med13 Mediator complex member Twi and DMef2
intron, and 30
crp FBgn0001994 Tcfap4 bHLH Twi and DMef2
50 and intron
Gug FBgn0010825 Atrophin1 and Rere chromatin regulator Twi and DMef2
50 and intron
nom FBgn0037617 — zinc-finger containing Twi 50
Elo-B FBgn0023212 Elongin-B elongation factor Twi and DMef2
50 and 30
lola FBgn0005630 ZBTB20 zinc-finger containing Twi and DMef2
50, intron and 30
Alh FBgn0261238 AF10/AF17 zinc-finger containing Twi and DMef2
50, intron and 30
Kdm2 FBgn0037659 Kdm2 histone demethylase Twi and DMef2
50, intron and 30
Sin3A FBgn0022764 Sin3A chromatin regulator Twi and DMef2
50 and intron
Genes were scored as having proximal Twist or DMef2 binding sites if a prior whole-genome ChIP on Chip experiment (Zinzen et al., 2009) identified
a binding site within 30 kb of the gene. Whether these sites are located 50 or 30 to the coding region or within intronic sequences is noted. See also
Figure S1.significant defects for most of the genes (Figure S3). Finally,
where available, we stained embryos expressing the FC-specific
transgene rplacZ with antibodies against these proteins to show
that they were expressed in themuscle. We detected expression
of Alh, Chn,Med13/Skd, Sin3A, andCrp in FCs (Figure S4).While
some of the genes were expressed in most or all FCs (e.g., Sin3A
and Med13/Skd), others were expressed only in a subset of
FCs (e.g., Chn). Additionally, we detected Elo-B with an anti-
body against the human protein in the musculature of stage 16
embryos (Figure S4).
We performed a comparative analysis to test whether other
studies supported a role for these identified genes in muscle
development. Global chromatin immunoprecipitation studies
identified Twi or DMef2 binding sites within the introns of or
in close proximity to all 11 genes (Table 1) (Zinzen et al.,
2009). Additionally, RNA polymerase II has been shown to
bind to the promoters of Med13, crp, lola, chn, Elo-B, Alh,
Kdm2, lid, and Sin3A in purified muscle cells (Weake et al.,Figure 1. FACS and Transcriptional Profiling of Drosophila Muscle Fou
(A–C) Fluorescent transgenesmarked subsets ofmuscle cells for FACS. Diagram o
FCs develop at stage 16 (right). Confocal projections show transgene expression a
the fluorophore phycoerythrin.
(D) Overlap between the gene lists derived from the microarray results.
(E) GO Biological Process categories found to be enriched in FCs.
See also Tables S1, S2, and S3.2011). This study also found that the transcriptional coactivator
complex SAGA bound to the promoters of lola, chn, Elo-B, Alh,
Kdm2, lid, and Sin3A in muscle cells and showed that Chn, Alh,
and Sin3A interact directly with the SAGA complex (Weake
et al., 2011). In aggregate, comparison of our data to these
whole-genome studies confirmed the roles of these factors in
the somatic musculature but underscored the importance of
in vivo experiments to demonstrate functional significance
and identify specific muscles and pathways where these fac-
tors play a role.
Sin3A, EloB,Gug/Atrophin, crp, and lola have also been previ-
ously implicated in the development of adult muscle (Schnorrer
et al., 2010). Sin3A has been well characterized as a general
chromatin regulator and has been shown to play an important
role in vertebrate somitogenesis, myotube differentiation, and
sarcomere formation (Cunliffe, 2008; Sheeba et al., 2007; Shi
andGarry, 2012; van Oevelen et al., 2010). Since the role of chro-
matin regulators in the establishment of muscle identity hasnder Cells
f FCs labeled by each transgene at stage 13 (left) and into whichmuscles those
t stage 13 and representative sort plots show positive cells. ‘‘PE-A’’ designates
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Figure 2. Mutants for Genes Identified by
Microarray Display Muscle Phenotypes
(A) Diagram of wild-type muscle pattern of three
hemisegments at stage 16. The LT muscles are
green, and the VA muscles are magenta.
(B–M) Stage 16 embryos stained with anti-myosin
heavy chain (MHC). In this and all following figures,
unless indicated, approximately three hemiseg-
ments are shown, Scale bar, 25 mm. In the wild-
type embryo, the LT and VA muscles of one
hemisegment are outlined with dashed lines.
Mutant phenotypes are indicated by filled arrows
(misshapen), open arrows (missing muscles), line
arrows (extra muscles), filled arrowheads (mis-
attached muscles), and open arrowheads (unat-
tached myospheres).
(N) Percentage of hemisegments (blue) and em-
bryos (orange) displaying aberrant phenotypes in
each mutant background. Five abdominal hemi-
segments from at least 20 embryos for each ge-
notype were quantified.
See also Figures S2–S4.never been characterized, we investigated Sin3A in the genera-
tion of muscle diversity.
Sin3A Mutants Display Muscle Defects
We examined several loss-of-function Sin3A alleles for aberrant
muscle phenotypes (Figures 3A–3D). Homozygous mutants for
Sin3A08269, a partial loss-of-function allele caused by a trans-
posable element insertion into the first intron, exhibited a range862 Cell Reports 8, 858–870, August 7, 2014 ª2014 The Authorsof muscle phenotypes (Figures 2C, 3B,
and S2C). Muscle defects were observed
in 100% of embryos and 100% of
abdominal hemisegments, and 100% of
homozygous mutants died as embryos
(Figures 2N, 3E, and S2N and data
not shown). The ethyl methanesulfonate/
X-ray-generated allele Sin3Ae64 and the
transposable element insertion allele
Sin3AEP2387 showed strong patterning
defects, including germband retraction
failure (Figures 3C and 3D). In mutants
carrying these two alleles, we were un-
able to distinguish a segmentally
repeated muscle pattern and could
detect unfused myoblasts. Together,
these phenotypes suggest that the Si-
n3Ae64 and Sin3AEP2387 alleles have early
defects in embryonic patterning and
mesodermal specification, which is
consistent with the abnormal cuticle
pattern in these mutants (Figure S3 and
data not shown). In contrast, the
Sin3A08269 allele generated a recogniz-
able muscle pattern and did not display
early defects. For these reasons, we
focused subsequent studies on the
Sin3A08269 allele.The segmentally repeated muscle pattern is generated in part
in response to signals from the overlying ectoderm to the meso-
derm during development (Baylies and Michelson, 2001). To
ensure that the muscle defects in Sin3A08269 embryos were not
due to a disruption of ectodermal patterning, we stained em-
bryos for StripeA (SrA), a marker of mature tendon cells (Figures
3F and 3G) (Volk, 1999). SrA-expressing tendon cells are visible
along the segment border in Sin3A08269 mutants (Figure 3G,
arrows), indicating that these cells are properly specified
and positioned. These results are consistent with the wild-
type cuticle pattern in Sin3A08269 mutants (Figure S3). The
Sin3A08269 allele presents a unique genetic tool to examine the
role of Sin3A in the generation of muscle diversity.
To confirm the muscle defects in Sin3A08269 mutants, we
analyzed two sets of muscles in the muscle pattern: the four
lateral transverse muscles (LTs 1–4) and two ventral acute
muscles (VA1 and VA2). The centrally located LTs have simple,
elongated shapes, dorsal-ventral orientations, and single attach-
ment sites at the dorsal and ventral ends of the muscles. LT4 has
a characteristic positional shift dorsally. The ventrally located
VA1 and VA2 muscles are flag shaped, extending diagonally
fromanattachment to the posterior segment border in each hem-
isegment. VA2 has a distinctive downward curve, while VA1
extends across the hemisegment. In Sin3A08269 mutants, the
LTs were often misshapen and frequently attached incorrectly
(Figures 3B and 3E). We also frequently observed missing or un-
attached LTs; unattached muscles did not adopt an elongated
morphology (Figures 3B and 3E). We observed VA1 and VA2
defects much less frequently but did detect muscle misattach-
ments and mild changes in muscle shape (Figures 3B and 3E).
To test whether the LT and VA FCs have been specified
correctly in Sin3A08269 mutants, we examined expression of the
identity gene transcription factors Kr and Slou. LT2, LT4, VA1,
and VA2 are specified correctly in Sin3A08269 mutants (Figures
4A–4F). Additionally, in Sin3A08269 mutants, all four LT muscles
expressed an apME-NLS::dsRed transgene that is detectable in
the nuclei (Figures 4E–4J) (Richardson et al., 2007; Metzger
et al., 2012). It was apparent from the expression of apME-
NLS::dsRed transgene that fusion occurs in the Sin3A08269
mutant, but due to morphological defects, the nuclei are not
well spread out,making determination of final nuclei number diffi-
cult (Figures 4E–4J). The expression of Kr, Slou, and the apME-
NLS::dsRed transgene confirmed that the LT and VA muscles
retained their essential identities, despite the morphological
changes undergone by these muscles in Sin3A08269 mutants.
The misattachment phenotypes observed in Sin3A08269 mu-
tants were reminiscent of mutations in the integrin-encoding
genes multi edematous wings (mew, aPS1 integrin) and myo-
spheroid (mys, bPS integrin). These integrins are critical for
the formation of muscle and tendon attachments (Volk, 1999).
Additionally, Sin3A positively regulates the vertebrate homologs
Itga7 and Itgb1 in C2C12 myoblasts (van Oevelen et al., 2010).
We examined Mew and Mys expression in Sin3A08269 embryos
by staining and quantitative PCR analysis and found reduced
expression in Sin3A08269 mutants (Figure S5). Interestingly,
greater differences in Integrin expression were seen in the LTs.
While Mew and Mys expression at the segment border was dis-
rupted, expression at the ends of the LTmuscles was completely
absent. This reduction in Integrin expression most likely contrib-
utes to the attachment defects observed in Sin3A08269 mutants.
Genetic Interaction between Sin3A and Identity Gene
Transcription Factors
Studies in vertebrate muscle have pointed to a role for chromatin
structure during many steps of skeletal myogenesis (Sartorelli
and Juan, 2011; Fong et al., 2012). Recent work in neuronshas also demonstrated a role for chromatin regulators in modu-
lating the response to transcription factors in the determination
of neuronal cell fate (Poole et al., 2011; Tursun et al., 2011; Wein-
berg et al., 2013). We hypothesized that Sin3A performs an anal-
ogous function in the Drosophila musculature, thereby altering
identity gene transcription factor response. We therefore genet-
ically reduced the dosage of Sin3A by half and tested whether
overexpression of identity genes in this background led to
changes in the muscle pattern.
The VA muscles provide one of the few examples of direct
muscle transformation (Ruiz-Go´mez et al., 1997). Previous ex-
periments found that driving UAS-Kr expression with the strong
mesodermal driver twi-Gal4;24B-Gal4 results in the transforma-
tion of muscle VA1 to VA2 at a low penetrance (Ruiz-Go´mez
et al., 1997). In contrast, we observed no muscle defects when
the DMef2-Gal4 driver was used to express UAS-Kr (Figure 5A).
The lack ofmuscle defects in these embryos provided a sensitive
assay to examine the effects of Sin3A loss on muscle morpho-
genesis. We tested whether overexpression of Kr by DMef2-
Gal4 would lead to more severe muscle defects in a Sin3A08269
heterozygous background and found, remarkably, that 55% of
embryos reproducibly displayed the muscle transformation of
VA1 into VA2 (Figures 5B and 5J).
Since reduction of Sin3A expression affects VA muscle iden-
tity, we next examined the effect of Sin3A overexpression on
the muscle pattern. In Drosophila, multiple Sin3A protein iso-
forms are expressed in the embryos that differ in their C-terminal
domain (Spain et al., 2010). We drove expression of the 187 and
220 kDa isoforms of Sin3A with DMef2-Gal4 or twi-Gal4; 24B-
Gal4. Similar to what we and others have observed with overex-
pression of Kr, we observed much stronger defects in embryos
where twi-Gal4; 24B-Gal4 was used to drive transgene expres-
sion rather than DMef2-Gal4 (data not shown) (Ruiz-Go´mez
et al., 1997). Embryos in which UAS-Sin3A-187 was misex-
pressed in the mesoderm displayed a range of defects in the
somatic musculature (Figures 5C and 5D). While half of the em-
bryos displayed a wild-type pattern (Figure 5C), the other 50%of
embryos show missing and misshapen muscles (Figure 5D).
Strikingly, we detect the opposite VA2 to VA1 muscle transfor-
mation in a subset (14%) of embryos (Figures 5D and 5J). Misex-
pression of UAS-Sin3A-220 in the mesoderm did not result in
severe muscle defects or VA2 to VA1 muscle transformations
(Figure 5E), suggesting that the Sin3A-187 isoform is the more
active isoform in the mesoderm. This result is consistent with a
role for Sin3A-187 in differentiating cells (Spain et al., 2010).
To confirm the VA muscle transformations, we stained em-
bryos for Slou expression. Slou protein is expressed in VA2 in
wild-type embryos and is activated by Kr (Figure 5F) (Ruiz-Go´-
mez et al., 1997). In Sin3A08269 heterozygous embryos in which
UAS-Kr is being driven by DMef2-Gal4, Slou was visible in
two VA muscles, confirming the VA1 to VA2 transformation
(Figure 5G). We did not observe ectopic expression of Slou else-
where in the muscle pattern (data not shown). In twi-Gal4; 24B-
Gal4 > UAS-Sin3A-187 embryos, we no longer detect Slou
staining in either of the two ventral muscles, consistent with a
VA2 to VA1 transformation (Figure 5H) (Ruiz-Go´mez et al., 1997).
We next examined expression of slou transcript in wild-type
and Sin3A08269 homozygous embryos by quantitative RT-PCR.Cell Reports 8, 858–870, August 7, 2014 ª2014 The Authors 863
Figure 3. Mutant Phenotypes of Sin3A Mutant Embryos
(A–D) Wild-type (OreR) and Sin3A homozygous mutant embryos stained for MHC. Scale bar, 25 mm. In (B), mutant phenotypes are indicated by filled arrows
(misshapen), open arrows (missing muscles), filled arrowheads (misattached muscles), and open arrowheads (unattached myospheres).
(legend continued on next page)
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Figure 4. Identity Gene Expression in Sin3A Mutant Embryos
Wild-type and Sin3A08269 mutants stained with antibodies against FC markers. Scale bar, 25 mm.
(A and B) Stage 13 embryos stained with anti-Kr (green).
(C and D) Stage 13 embryos stained with anti-Slou (green).
(E and F) Wild-type and Sin3A08269 embryos expressing the apME-NLS::dsRed transgene.
(G and H) Stage 16 embryos stained with anti-MHC (green) and anti-dsRed (white in single channel, magenta in merge) to shown nuclear pattern.
(I and J) Live images of stage 17 embryos expressing the apME-NLS::dsRed transgene (white).slou expression was significantly increased in Sin3A08269 homo-
zygous mutants (Figure S6A), demonstrating that, in the whole
embryo, reduction of Sin3A affected the levels of slou transcript.
Despite this overall increase in expression, we do not see
changes to the pattern of Slou expression in Sin3A08269 mutants
without misexpression of Kr (Figure 5I). Loss of Sin3A appears to
permit increased Slou expression only in muscles where Slou is
normally expressed. This result suggests that slou is dere-
pressed by loss of Sin3A but requires positive activation of
slou by Kr and other slou activators. Finally, ChIP experiments
in wild-type embryos revealed an enrichment of Sin3A at the
slou mesodermal enhancer, suggesting that the repression of
slou by Sin3A was direct (Figure 5K).
To test whether the muscle transformations were the result
of a specific genetic interaction between Sin3A and Kr, or if
Sin3A had a more general effect on muscle responsiveness
to identity gene expression, we misexpressed UAS-ara with
DMef2-Gal4. As with Kr, we observed an enhancement of aber-
rant muscle phenotypes by misexpressing ara in Sin3A08269 het-
erozygous embryos when compared with misexpression in a
wild-type background, including an increased number of LT
muscles (Figures S6B and S6C). We concluded that muscle
changes are not confined to a specific genetic interaction be-
tween Sin3A and Kr but are likely an effect of global changes
to chromatin structure that could affect responsiveness of target
genes to all identity genes.
To explore the genetic interactions between Sin3A, Kr and ara
further, we examined embryos transheterozygous for Sin3A08269
and either the Kr mesodermal loss-of-function allele P[ry+ KrCD]
bw Kr1 or the ara and caup deficiency Df IroDFM3 (Carrasco-
Rando et al., 2011; Ruiz-Go´mez et al., 1997). We failed to(E) Quantification of mutant phenotypes in Sin3A08269 homozygous embryos. Fiv
quantified.
(F and G) Wild-type and Sin3A08269 embryos stained for MHC (white in single cha
Arrows point to SrA-expressing tendon cells.
See also Figure S5.observe mesodermal defects in these transheterozygous em-
bryos (Figures S6D–S6F). This result is consistent with a mecha-
nism in which the activity of Sin3A in wild-type embryos opposes
the activities of Kr and Ara.
Kr is a positive regulator of slou in the ventral muscles (Ruiz-
Go´mez et al., 1997). Taken together, our work demonstrates a
role for Sin3A in this process: titrating the ability of muscles to
respond to the Kr signal (Figure 6). In wild-type embryos, the
VA1 and VA2 FCs are derived from the same Kr-expressingmus-
cle progenitor. Kr expression is turned off in VA1 but remains on
to activate slou in VA2. Our data suggest that Sin3A maintains
slou in a repressed state in VA1, potentially helping to mediate
the transition of this FC from a Kr-positive to a Kr-negative state.
Loss of Sin3A alleviates this repression, allowing slou to be
ectopically activated by Kr in VA1 and transforming it to VA2.
This interpretation explains the differences in phenotypes seen
when different Gal4 drivers are used: while moderate Kr levels
(such as those driven by DMef2-Gal4) are insufficient to drive
an increase in slou expression if that locus has not been dere-
pressed by reduction of Sin3A activity, embryos expressing
higher Kr levels (such as those driven by twi-Gal4; 24B-Gal4)
are able to activate expression of slou. Similarly, high levels of
Sin3A overexpression, such as those driven by twi-Gal4; 24B-
Gal4, are required to prevent activation of slou by Kr in VA2. It
is possible these differences are also a result of the slightly earlier
expression of twi-Gal4; 24B-Gal4. Consistent with a role for
Sin3A as a factor that modulates muscle response to identity
genes, we do not observe the VA2 to VA1 muscle transformation
in 100% of muscles or hemisegments in embryos where Sin3A is
overexpressed, suggesting that the transformation depends on
the endogenous state of gene expression in individual embryos.e abdominal hemisegments from at least ten embryos for each genotype were
nnel, green in merge) and StripeA (white in single channel, magenta in merge).
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Figure 5. Alteration of Muscle Identity in Sin3A Gain- and Loss-of-Expression Embryos
(A and B) Stage 16 embryos stained with anti-MHC. Arrow points to the VA1 to VA2muscle transformation in Sin3A08269/+; DMef2-Gal4 > UAS-Kr embryos. 55%
of embryos in (B) display the muscle transformation (n = 20). Scale bar, 25 mm.
(C–E) Stage 16 embryos stainedwith anti-MHC expressing either the 187 or 220 kDa isoforms ofUAS-Sin3A under the control of twi-Gal4; 24B-Gal4. Arrow points
to VA2 to VA1 muscle transformation (14% of embryos, n = 56).
(F–I) Slou expression (white in single channel, magenta in merge) in the VA muscles of stage 16 Sin3A08269 mutant embryos. Scale bar, 15 mm. Embryos are also
stained with anti-MHC (green) to showmuscle pattern, and VA1 and VA2 are outlined with dashed lines. One hemisegment is shown. Arrows point tomuscle VA2.
(J) Quantification of ventral muscle transformations in Sin3A gain and loss of function embryos. Five abdominal hemisegments from at least 20 embryos for each
genotype were quantified.
(K) ChIP was performed on extracts from wild-type embryos at stage 13 with anti-Sin3A. The presence of the sloumesodermal enhancer or a control region was
assayed in precipitated samples by quantitative PCR. Sin3A binding was significantly enriched at the sloumesodermal enhancer (blue) compared to the control
region (orange, p = 0.045) as well as relative to mock (purple, p = 0.003). Error bars indicate SD.
See also Figure S6.We conclude that Sin3A activity could sensitize certain FCs
and muscles to identity gene transcription factors, refining the
combinatorial code and ensuring muscle diversity.
DISCUSSION
Prior FACS and transcriptional profiling of Drosophila muscle
cells has focused on identifying differences between FCs and
FCMs and examining global effects of identity gene misexpres-
sion (Artero et al., 2001; Busser et al., 2012; Estrada et al.,866 Cell Reports 8, 858–870, August 7, 2014 ª2014 The Authors2006). Two of these studies used genetic manipulation to enrich
for FC and FCM populations (Artero et al., 2001; Estrada et al.,
2006). Our sorting strategy purified very small populations of
FC subsets from wild-type embryos for analysis. By this
approach, we observed significant overlap in the transcriptional
profiles of these two muscle subsets, defining a group of factors
common to FCs and suggesting that a relatively small number of
genes encode factors responsible for muscle diversity in each
population, while the rest comprise a ‘‘molecular signature’’ for
all FCs. We then screened homozygous mutant embryos for
Figure 6. A Model for VA1 and VA2 Identity
Diagram showing the development of the VA1 and
VA2 muscle FCs (top, green circles) into muscles
(green, bottom). Kr expression is depicted by a
blue line around the FC. The fate of the ventral
muscles is shown in (A) wild-type, (B) Sin3A08269/+;
DMef2-Gal4 > UAS-Kr and (C) twi-Gal4; 24B-
Gal4 > UAS-Sin3A-187.muscle defects. The strong combination of FACS, microarray,
and mutant analysis has so far identified 11 factors with roles
in Drosophila embryonic muscle development, 10 of which
have already been shown to have mammalian homologs. While
this work has focused on a number of factors that were found
to be enriched in both FC subsets, examination of FC subset-
specific factors is ongoing and promises to yield additional
genes regulating morphogenesis of muscle subsets.
Our screen identified a number of ubiquitously expressed
essential genes, which can be difficult to identify using forward
genetic screening due to maternal loading and early functions
during embryogenesis. Factors like Med13, Elo-B, and Sin3A
are required for the regulation of transcription in most cells and
tissues. Our approach enabled the discovery of muscle-specific
roles for these general transcriptional regulators, broadening our
understanding of the genetic network that controlsmuscle devel-
opment and setting the stage for future studies into themolecular
mechanisms that regulate the establishment of muscle diversity.
Our array and screen identified roles for 11 transcription fac-
tors and chromatin modifiers, effectively doubling the list of tran-
scriptional regulators known to control muscle development in
the Drosophila embryo. The conservation of these factors opens
up the possibility that roles for these factors will be found in
vertebrate myogenesis as well. The various mutant phenotypes
we observed suggest that the identified genes may have defined
functions in specific aspects of muscle development: FC speci-
fication or cell viability for muscle loss, muscle guidance andmy-
otendinous junction formation for muscle misattachment and FC
specification, and cytoskeleton regulation for shape changes.
Future work will focus on identification of specific regulatory tar-
gets to determine the distinct roles played by these factors at
particular steps in development.
Interestingly, although we detect expression of Sin3A in all
FCs in the muscle pattern, we detect phenotypic changes in
Sin3A08269 mutants primarily within the LTs. It is clear from anal-Cell Reports 8, 858–8ysis of the stronger Sin3Ae64 and Si-
n3AEP2387 alleles that Sin3A is required
throughout the musculature for earlier
myogenesis steps like myoblast fusion.
We attribute the lack of defects in all 30
muscles in Sin3A08269 mutants to two
causes: (1) the weaker nature of the
Sin3A08269 allele and (2) the integration
of Sin3A into the complicated genetic
network of previously characterized
identity genes. Our subsequent experi-
ments in which misexpression of Kr in
Sin3A08269 heterozygotes leads to VAmuscle transformations supports the theory that Sin3A still plays
a role in muscles even if we do not see perturbations to those
muscles in Sin3A08269 homozygotes. Additionally, we found
that overexpression of the Sin3A-187 isoform in the mesoderm
led to muscle transformations, while overexpression of the
Sin3A-220 isoform did not. This result is consistent with previous
studies showing that Sin3A-187 is the dominant isoform in differ-
entiated tissues and has greater histone deacetylase activity
than Sin3A-220. The data suggest that Sin3A-187 isoform is
more active in the muscle tissue at genes required for the spec-
ification of muscle fate.
How is muscle identity regulated by identity genes? The idea
of a combinatorial code specifying muscle fate predicts that
the DNA-binding transcription factors work cooperatively and/
or antagonistically to generate a muscle-specific transcriptional
profile. The incomplete overlap of identity gene expression gen-
erates some specificity, as does the timing of identity gene
expression (Carrasco-Rando et al., 2011; Tixier et al., 2010).
But how do identity genes work once they have bound to the
DNA? What factors ensure that the correct FCs respond to
signals from identity genes? Our results suggest Sin3A is a factor
that titrates the responsiveness of muscles to identity genes.
Genetic reduction of Sin3A levels leads VA1 to be susceptible
to overexpression of the identity gene Kr, ectopically activating
Slou expression in this muscle and resulting in VA1 to VA2 trans-
formation. In contrast, overexpression of Sin3A prevents activa-
tion of Slou in VA2 and drives VA2 to VA1 transformation.
One hypothesis to explain our results is that the ability of Kr to
activate Slou expression in a given muscle depends on the his-
tone modification landscape over the slou promoter, which is
in turn regulated by Sin3A histone deacetylase activity. This
model suggests that one critical factor contributing to muscle
competence is chromatin structure. Our model is built upon ob-
servations of specific single muscle transformations in the em-
bryonic somatic musculature. The challenge going forward will70, August 7, 2014 ª2014 The Authors 867
be to design methods to monitor transcription factor binding,
chromatin structure, and gene expression changes at themolec-
ular level in a relatively small percentage of cells in the embryo.
The muscle transformation results we observe are similar to
studies from the C. elegans nervous system, in which chromatin
regulators have been shown to play important roles in the termi-
nal differentiation of neurons (Doitsidou et al., 2013; Poole et al.,
2011; Tursun et al., 2011; Weinberg et al., 2013). Our work ex-
tends these findings to the Drosophila musculature, suggesting
a more global role for chromatin regulation in tissue diversity
and differentiation. It is possible that the other chromatin modi-
fiers found in our screen, Lid and Kdm2, will be found to play
roles in this process as well.
Our results draw a distinction between Sin3A and the well-
characterized identity genes. While Sin3A is required for the cor-
rect formation of muscles, its absence does not change FC
specification. This lack of phenotype likely indicates that other
positive regulators of transcription are required to drive fate
changes in these muscles; alternatively, it could also be that a
stronger depletion of Sin3Awould causemuscle transformations
but that this phenotype is obscured by the earlier patterning de-
fects we observe with stronger alleles. It is important to note that
Sin3A08269 homozygous mutant embryos do not display VA1 to
VA2 transformations, despite overall derepression of slou tran-
script. While loss of Sin3A disrupts the muscle pattern, it is
only in concert with identity gene misexpression that we detect
its role in muscle diversity, underscoring the importance for the
identity genes in prescribing final muscle characteristics.
Additionally, though overexpression of Sin3A in themesoderm
can lead to VA2 to VA1 transformations, this change does not
happen in every hemisegment. Sin3A is just one factor contrib-
uting to muscle identity in the context of each muscle’s specific
network of gene expression. Our experiments reveal the strong
commitment to a specific cell fate each muscle makes during
development. The somatic musculature is particularly resistant
to perturbations; we show that overexpression of Kr can only
cause muscle transformations when a strong Gal4 driver is
used. In this way, formation of muscle identity is analogous to
a buffered solution. In this system, reduction of Sin3A is like
removing the buffer, allowing more frequent muscle identity
changes. Sin3A, then, positively contributes to the establishment
of muscle diversity by fortifying the muscles against shifts in
gene expression.
Regulators of chromatin structure have been increasingly
shown to play important roles in muscle development and dis-
ease (Fong et al., 2012; Puri and Sartorelli, 2010; Sartorelli and
Juan, 2011). Sin3A, in particular, has been shown to regulate
the expression of several genes that have been implicated in
muscular dystrophies (van Oevelen et al., 2010). While chromatin
regulators have been implicated in muscle cell differentiation,
Sin3A is the first to be shown to have a role in the formation of
muscle identity. A key gap in our knowledge about the specifica-
tion of muscle identity has been that misexpression of identity
genes results in relatively few direct muscle transformations.
Our results add a layer of complexity to the combinatorial code
model for the generation of muscle diversity, suggesting that
the epigenetic landscape of a particular muscle sets the stage
for identity gene response, either by modulating transcription868 Cell Reports 8, 858–870, August 7, 2014 ª2014 The Authorsfactor binding or fine tuning the activity of factors once bound
to mesodermal enhancers. This knowledge will be critical to syn-
thesize muscles of specific sizes and shapes for use in stem cell
transfer therapies to treat muscle disease.
EXPERIMENTAL PROCEDURES
Fly Stocks
Drosophila stocks and crosses were grown on standard cornmeal medium at
25C. The GAL4-UAS system (Brand and Perrimon, 1993) was used for
expression studies. OreR was used as a control strain. Embryos were staged
according to Campos-Ortega and Hartenstein (1985). Approximate ages are
stage 12 (7:20–9:20 hr AEL), stage 13 (9:20–10:20 hr AEL), and stage 16
(13:00–16:00 hr AEL). For a list of fly stocks used in this study, please see Sup-
plemental Experimental Procedures.
FACS, RNA Isolation, and Microarray Analysis
Flies expressing GFP or red fluorescent protein (RFP) transgenes were main-
tained at 25C on a 12 hr light/12 hr dark cycle. After a 2 hr prelay, flies were
allowed to lay on plates for 2 hr; these plates were removed and aged for an
additional 8 hr. Embryos were dissociated into a single-cell suspension
(Dobi et al., 2011). Cells were sorted using standard methods on a Beckon-
Dickson FACS Aria Cell Sorter (Estrada and Michelson, 2008). Total cellular
RNA from each sample was prepared from sorted cells using TRIzol LS Re-
agent without amplification (Invitrogen). Total cellular RNA was labeled and
hybridized to Drosophila Affymetrix GeneChip 2.0 arrays according to the
manufacturer’s instructions. Three independent sorts were made for each
transgene, and each RNA sample was independently labeled and hybridized.
For apME-GFP, we sorted 1,000,000 GFP-positive cells from 43 10
8 starting
cells, a positive rate of 0.03%, which yielded 1 mg of RNA. The purity upon
resort of the cells was 74%. The purity of S59ME-RFP and twiprom-actin-GFP
was 87% and 95%, respectively, with positive rates and yields also corre-
spondingly higher.
Affymetrix microarray data were normalized and compared with Partek
Genomics Suite Software. apterousME-GFP- and slouchME-RFP-positive cells
were compared to twiprom-actin-GFP-expressing cells to generate lists of
differentially regulated genes, fold changeR 1.7, p value < 0.05. DAVID v6.7
was used to assign GO classifications to the genes identified by the array
(Huang et al., 2009a, 2009b). Default parameters were used to perform Func-
tional Annotation of gene lists, p value < 0.05.
In Situ Hybridization
Probes for in situ hybridization were made using clones from the Drosophila
Genomics Resource Center collection (Stapleton et al., 2002). Hybridizations
were performed as in Leatherbarrow and Halfon (2009). For additional detail,
please see Supplemental Experimental Procedures.
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde/heptane for all immunohisto-
chemistry. Primary antibodies were detected using Alexa-conjugated second-
ary antibodies (1:400; Invitrogen). Embryos were mounted in Vectashield
(Vector Laboratories) or ProLong Gold antifade reagent (Invitrogen). Double
or triple staining using anti-b-galactosidase or anti-GFP was used to identify
the presence of marked balancer chromosomes. For antibody sources and
concentrations, please see Supplemental Experimental Procedures.
Fluorescent images were acquired on a Leica SP5 laser-scanning confocal
microscope equipped with a 633 1.4 numerical aperture HCX PL Apochromat
oil objective and LAS AF 2.2 software. Images were processed using Adobe
Photoshop CS4. Maximum-intensity projections of confocal z stacks were
rendered using Volocity Visualization software (Improvision).
Production of cDNA and Quantitative PCR
Wild-type (OreR) and Sin3A08269 homozygous embryos were collected, de-
chorionated, and staged by embryo morphology, and 10–20 stage 13 or 16
embryos per sample were lysed and transferred to TriReagent (Sigma). Total
mRNA was prepared according to manufacturer’s instructions and
resuspended in RNase-free water, and 1 mg of total mRNA was used to pre-
pare first-strand cDNA using the Superscript III Reverse Strand Synthesis Sys-
tem (Invitrogen). For quantitative PCR (qPCR), first-strand cDNA product was
1:5 in Blue qPCR SYBR Low Rox Master Mix (Thermo Scientific). qPCR was
conducted using an Applied Biosystems 7500 Real Time PCR System.
qPCR results were analyzed and relative ratios of Slou transcripts (normalized
to rp49 levels) in OreR and Sin3A08269 mutants were determined using
described methods (Pfaffl, 2001). For primer sequences, please see Supple-
mental Experimental Procedures.
ChIP
We performed ChIP on stage 13 wild-type (OreR) embryos (Nien et al., 2011).
ChIP lysates were immunoprecipitated with preimmune serum or anti-Sin3A
(Spain et al., 2010). Gene-specific qPCR of purified DNA was performed as
described above. Significance of binding enrichment was determined using
a Student’s t test. For a list of primers, please see Supplemental Experimental
Procedures.
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